FISPB
DYN icon

Fideuram - Intesa Sanpaolo Private Banking’s Dyne Therapeutics DYN Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
+87,069
New +$1.62M 0.06% 233
2026
Q1 		– Sell
-200
Closed -$3.91K – 479
2025
Q4 		$3.91K Buy
+200
New +$3.79K ﹤0.01% 418

Other funds holding DYN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's DYN Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 87,069 shares worth $1.93M. The stake represents 0.06% of the portfolio and ranks #233 among its holdings. This is a return to the name: Fideuram - Intesa Sanpaolo Private Banking previously reported a position in DYN as recently as Q4 2025.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in DYN in Q4 2025 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 87,069 shares of Dyne Therapeutics worth $1.93M as of Q2 2026.
  • Dyne Therapeutics was a new Fideuram - Intesa Sanpaolo Private Banking position in Q2 2026.
  • Dyne Therapeutics made up 0.06% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #233 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.